nVerses Capital’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Sell
5,209
-7,633
-59% -$275K 0.36% 146
2026
Q1
$413K Buy
+12,842
New +$456K 0.38% 87
2024
Q2
Sell
-100
Closed -$5.2K 1220
2024
Q1
$5.2K Buy
+100
New +$4.38K 0.01% 577

Other funds holding VCEL

nVerses Capital's VCEL Position: Q2 2026 in Review

nVerses Capital reduced its Vericel Corp (VCEL) stake by 59% in Q2 2026, selling an estimated $275K and leaving 5,209 shares worth $232K. The position accounts for 0.36% of the portfolio, ranked #146.

nVerses Capital first reported a position in VCEL in Q1 2024 and has held it in 3 quarters since. The position peaked at $413K in Q1 2026. 237 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • nVerses Capital held 5,209 shares of Vericel Corp worth $232K as of Q2 2026.
  • nVerses Capital sold 7,633 Vericel Corp shares in Q2 2026, an estimated $275K.
  • Vericel Corp made up 0.36% of nVerses Capital's portfolio in Q2 2026, its #146 holding.
  • nVerses Capital first reported a position in Vericel Corp in Q1 2024 and has held it in 3 quarters since.
  • nVerses Capital's Vericel Corp position peaked at $413K in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.